Plain-English translation of NCT07621055 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Atrial Fibrillation research guide →This trial is testing Volta AF-Xplorer II, an artificial intelligence software tool that helps doctors map and identify problem areas in the heart during ablation surgery for atrial fibrillation (irregular heartbeat). All participants will undergo the ablation procedure using this new AI mapping technology, followed by regular check-ups for 2 years to track how well the treatment works and any side effects.
Doctors need better tools to pinpoint exactly where in the heart the irregular rhythm is coming from so they can treat it more effectively. This new AI software is designed to help them identify these problem areas more precisely during surgery.
You likely qualify if…
You likely don't qualify if…
You will undergo ablation surgery using the new AI mapping software, which helps your doctor identify and treat the problem areas in your heart. After surgery, you will have routine follow-up visits at 3 months, 6 or 9 months, and then yearly visits for 2 years, where doctors will check how you're doing, ask about any symptoms, and assess your quality of life. Throughout the study, doctors will monitor you for any side effects or recurrence of irregular heartbeat.
AI-generated summary from trial data · Aug 6, 2026 · Not medical advice
France